| 3D | Three dimensional |
| γ-GTP | γ-glutamyl transpeptidase |
| Akt | Protein kinase B |
| ALB | Albumin |
| ALP | Alkaline phosphatase |
| ALT | Alanine aminotransferase |
| AST | Aspartate aminotransferase |
| AT-LDL | A1-antitrypsin-LDL |
| AUC | Area under the curve |
| Bax | Bcl-2-like protein 4 |
| BCS | Biopharmaceutics classification system |
| BCVA | Best-corrected visual acuity |
| BMI | Body mass index |
| BS | Blood sugar |
| CAu-PLGA NPs | Gold-loaded PLGA nanoparticles |
| CCDC | Cambridge Crystallographic Data Centre |
| cfPWV | Carotid-femoral pulse wave velocity |
| CK | Creatine kinase |
| CMC | Critical micellar concentration |
| CNS | central nervous system |
| CRP | C-reactive protein |
| CYP3A4 | Cytochrome P450 3A4 |
| DbD | Delivery by Design |
| DOMS | Delayed onset muscle soreness |
| EGF | Epithelial growth factor |
| FAE | Follicle-associated epithelium |
| FDA | US Food and Drug Administration |
| GALT | Gut-associated lymphoid tissue |
| GB | Glioblastoma |
| GEM | Gemcitabine |
| GI | Gastrointestinal |
| GRAS | Generally regarded as safe |
| HDL | High-density lipoprotein |
| HDL-C | High-density lipoprotein cholesterol |
| IκBα | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor α |
| IL-1β | Interleukin-1β |
| IL-6 | Interleukin-6 |
| i.p. | Intraperitoneal |
| JKOM | Japanese knee osteoarthritis measure |
| JOA | Japanese orthopedic association |
| LDH | Lactate dehydrogenase |
| LDL | Low-density lipoprotein |
| LSCS-CUR | Lauroyl sulphated chitosan–curcumin |
| M cells | Microfold cells |
| MCT | Medium-chain triglyceride |
| MNPs | Magnetic nanoparticles |
| mPa·s | Millipascal second |
| NAFLD | Nonalcoholic fatty liver disease |
| NF-kB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| Nrf2 | Nuclear factor erythroid 2–related factor 2 |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| OCT | Optical coherence tomography |
| PARP | Poly (ADP-ribose) polymerase |
| PEG | Polyethylene glycol |
| PEG 400 | Polyethylene glycol 400 |
| PEO | Polyethylene oxides |
| PNS | Polar–nonpolar sandwich |
| PPO | Polypropylene oxide |
| PPs | Peryer’s patches |
| PLGA | Poly-(lactic-co-glycolic acid) |
| PVP | Polyvinyl pyrrolinone |
| QoL | Quality of life |
| OA | Osteoarthritis |
| ROS | Reactive Oxygen Species |
| sCD40L | Soluble CD40 ligand |
| SMEDDSs | Self-microemulsifying drug delivery systems |
| SLCPs | Solid lipid curcumin particles |
| SLNPs | Solid lipid nanoparticles |
| SLPs | Solid lipid particles |
| TAG | Triacylglycerols |
| TC | Total cholesterol |
| Tf | Transferrin |
| TG | Triglycerides |
| TNFα | Tumor necrosis factor α |
| TNFβ | Tumor necrosis factor β |
| UDP-glucuronosyltransferase | Uridine 5′-diphospho-glucuronosyltransferase |
| UMIN Clinical Trials | University hospital medical information network Clinical Trials |
| UV light | Ultraviolet light |
| VAS | Visual analog scale |
| WOMAC | Western Ontario and McMaster Universities’ arthritis index |